United Orthopedic Corporation commenced patient enrollment in a U.S. follow-up study of the U-Motion II+ Acetabular System and UTF Reduced Stem in...
Bioventus entered into a multi-year agreement with Institut Biochimique, gaining exclusive U.S. distribution rights for GELSYN-3™ 3-injection hyaluronic acid product for pain relief...
To offset the shifting economic and regulatory environment, Bill Tribe, Ph.D., partner at consulting firm A.T. Kearney, foresees the need...
Amid efforts to lower costs and increase value in the orthopaedic industry, sales and purchasing models are shifting. This is...
Materialise entered into an agreement with Mathys for use of 3D surgical planning software and patient-specific surgical guides with Mathys’...
FDA issued a final order requiring OEMs to submit a premarket approval application for certain metal-on-metal total hip replacement devices....
On 2/19/16, FDA’s Orthopaedic and Rehabilitation Devices Panel will meet regarding the PMA for Medtronic’s DIAM™ Spinal Stabilization System. ...
Bone Therapeutics has treated 12 patients in the ALLOB® Phase IIA spinal fusion trial, and reports no safety concerns....
The EOS imaging platform was granted Innovative Technology status in Korea, recognizing EOS as a unique modality worthy of a new reimbursement...
Silver Bullet Therapeutics was allowed a U.S. patent, "Bone Implants for the Treatment of Infection." ...
0 
